BIOHEART(02185)
Search documents
Wang Philip Li增持百心安-B1万股 每股均价约6.09港元
Zhi Tong Cai Jing· 2025-12-15 07:56
香港联交所最新数据显示,12月11日,Wang Philip Li增持百心安-B(02185)1万股,每股均价6.0906港 元,总金额60906港元。增持后最新持股数目为8509.77万股,持股比例为36.10%。 ...
Wang Philip Li增持百心安-B(02185)1万股 每股均价约6.09港元
智通财经网· 2025-12-15 07:54
智通财经APP获悉,香港联交所最新数据显示,12月11日,Wang Philip Li增持百心安-B(02185)1万股, 每股均价6.0906港元,总金额60906港元。增持后最新持股数目为8509.77万股,持股比例为36.10%。 ...
智通港股股东权益披露|12月11日


智通财经网· 2025-12-11 00:06
备注:持股数变动有可能因供股、合股、拆股等情况引起,请注意对照实际情况进行辨别。 | 股票名称 | 机构名称 | 性质 | 变动前持股 | 变动后持股 | 持股比 | | --- | --- | --- | --- | --- | --- | | 百心安-B(02185) | Wang Philip Li | 好仓 | 8507.77 万股 | 8508.77 万股 | 36.10%(最新) | | | | | | | 36.10%(前次) | | 赏之味(08096) | 林宇佐 | 好仓 | 2115.50 万股 | 940.00 万股 | 4.88%(最新) | | | | | | | 10.99%(前次) | | 赏之味(08096) | Goldstone 1 LPF | 好仓 | 2115.50 万股 | 940.00 万股 | 4.88%(最新) | | | | | | | 10.99%(前次) | | 赏之味(08096) | Goldstone Wealth | 好仓 | 2115.50 万股 | 940.00 万股 | 4.88%(最新) | | | Management | | | | ...
智通港股股东权益披露|12月9日



智通财经网· 2025-12-09 00:11
Core Viewpoint - The latest shareholder equity disclosures for several companies, including 百心安-B, 地平线, 积木集团, 中国宝力科技, and 中国港能, were made on December 9, 2025, highlighting changes in shareholdings among key institutional investors [1]. Group 1: 百心安-B (02185) - Wang Philip Li increased his holdings from 85.0577 million shares to 85.0677 million shares, maintaining a holding percentage of 36.09% [2]. - Winning Powerful Limited slightly increased its holdings from 45.8756 million shares to 45.8856 million shares, with a holding percentage of 19.47% [2]. Group 2: 地平线 (N24028) - Liu Qin reduced his holdings from 129 million shares to 102 million shares, resulting in a holding percentage decrease from 1.03% to 0.82% [2]. - Ni Yuanyuan also decreased her holdings from 129 million shares to 102 million shares, with the same holding percentage change [2]. Group 3: 积木集团 (08187) - Zhou Yifeng increased his holdings from 21.69 million shares to 28.99 million shares, raising his holding percentage from 14.30% to 19.11% [2]. Group 4: 中国宝力科技 (00164) - Xu Xueqin reduced her holdings from 26.70 million shares to 21.30 million shares, with a holding percentage decrease from 9.17% to 7.32% [2]. Group 5: 中国港能 (00931) - Lin Jiali completely divested from 10 million shares to 0 shares, resulting in a holding percentage drop from 0.18% to 0% [2].
港股异动 百心安-B(02185)现涨超4% IBERIS RDN系统近日在新西兰注册
Jin Rong Jie· 2025-12-08 05:03
华福证券此前发布研报称,百心安 Iberis RDN 系统是全球唯一获批上市能兼具经桡动脉(TRA)和经 股动脉双入路 RDN,先发优势显著,国内已与远大健康、海外多国家地区联合蓝帆柏盛达成重磅战略 合作;德国、法国已将 Iberis RDN 纳入医保,当前正为百心安商业化加速起点。 本文源自:智通财经网 智通财经获悉,百心安-B(02185)现涨超4%,截至发稿,涨4.13%,报6.56港元,成交额118.24万港元。 消息面上,百心安此前公告,附属公司上海安通医疗科技有限公司研发的Iberis 多极肾动脉射频消融导 管系统已在新西兰完成注册。Iberis RDN系统是全球唯一获准使用经桡动脉方法和经股动脉入路方法的 肾神经阻断产品。 ...
异动盘点1208 | 天域半导体上市次日反弹逾10%,锂业股逆市走高;矿业股普涨,Paramount Skydance跌超9%
贝塔投资智库· 2025-12-08 04:25
Group 1: Hong Kong Stocks - LeMo Technology (02539) surged nearly 17%, reaching a new high of 67.8 HKD, over 60% increase from the IPO price of 40 HKD [1] - Baixin An-B (02185) rose over 4% after announcing that its subsidiary completed the registration of the Iberis multi-polar renal artery radiofrequency ablation catheter system in New Zealand, the only product approved for both radial and femoral artery access for renal denervation [1] - Health Road (02587) increased over 2% as it announced plans to repurchase up to 100 million HKD of its shares in the open market, reflecting confidence in its business outlook [1] - Deutsche Bank Tianxia (02418) fell over 8% following a report that revealed 10 shareholders collectively held 98.9% of the company's issued H-shares, leaving only 1.1% for other investors [1] Group 2: Other Notable Stocks - Kailaiying (06821) rose nearly 2% as its Shanghai Fengxian commercial production base officially commenced operations, marking a significant upgrade in its biopharmaceutical CDMO capabilities [2] - Tianyu Semiconductor (02658) rebounded over 12% on its second day of trading, although still down 20% from its IPO price of 58 HKD [2] - Lithium stocks saw gains, with Ganfeng Lithium (01772) up 4.65%, Hongqiao Group (08137) up 2.15%, Tianqi Lithium (09696) up 3.29%, and CATL (03750) up 1.51% [2] - AAC Technologies (02018) rose nearly 2% after Alibaba launched its first self-developed flagship AI glasses, the Quark AI Glasses S1 [2] - Zhou Hei Ya (01458) increased over 5% as it announced the opening of its first overseas brand store in Malaysia on December 5, 2025 [2] Group 3: US Market Highlights - US mining stocks generally rose, with Albemarle (ALB.US) up 5.08% and MP Materials (MP.US) up 0.47%, amid reports of the US government planning to increase its stake in key mineral companies [5] - Paramount Skydance (PSKY.US) fell 9.82% after proposing a buyout of Warner Bros Discovery (WBD.US) at $30 per share, while Netflix (NFLX.US) offered $27.75 per share [5] - Intel (INTC.US) rose 2.25% after announcing it would retain its network and edge computing business, enhancing integration in AI and data center solutions [5] - Netflix (NFLX.US) dropped 2.89% while Warner Bros Discovery (WBD.US) rose 6.28% following Netflix's announcement of a $27.75 per share acquisition offer for Warner Bros [6] - Baidu (BIDU.US) increased by 5% as reports emerged that Kunlun Core is preparing for an IPO in Hong Kong, targeting early 2026 for its application [6]
港股异动 | 百心安-B(02185)现涨超4% IBERIS RDN系统近日在新西兰注册
Zhi Tong Cai Jing· 2025-12-08 03:56
华福证券此前发布研报称,百心安 Iberis RDN 系统是全球唯一获批上市能兼具经桡动脉(TRA)和经 股动脉双入路 RDN,先发优势显著,国内已与远大健康、海外多国家地区联合蓝帆柏盛达成重磅战略 合作;德国、法国已将 Iberis RDN 纳入医保,当前正为百心安商业化加速起点。 智通财经APP获悉,百心安-B(02185)现涨超4%,截至发稿,涨4.13%,报6.56港元,成交额118.24万港 元。 消息面上,百心安此前公告,附属公司上海安通医疗科技有限公司研发的Iberis 多极肾动脉射频消融导 管系统已在新西兰完成注册。Iberis RDN系统是全球唯一获准使用经桡动脉方法和经股动脉入路方法的 肾神经阻断产品。 ...
百心安-B现涨超4% IBERIS RDN系统近日在新西兰注册
Zhi Tong Cai Jing· 2025-12-08 03:53
消息面上,百心安此前公告,附属公司上海安通医疗科技有限公司研发的Iberis多极肾动脉射频消融导 管系统已在新西兰完成注册。Iberis RDN系统是全球唯一获准使用经桡动脉方法和经股动脉入路方法的 肾神经阻断产品。 华福证券此前发布研报称,百心安Iberis RDN系统是全球唯一获批上市能兼具经桡动脉(TRA)和经股动 脉双入路RDN,先发优势显著,国内已与远大健康、海外多国家地区联合蓝帆柏盛达成重磅战略合 作;德国、法国已将Iberis RDN纳入医保,当前正为百心安商业化加速起点。 百心安-B(02185)现涨超4%,截至发稿,涨4.13%,报6.56港元,成交额118.24万港元。 ...
百心安(02185) - 截至2025年11月30日止月份股份发行人的证券变动月报表
2025-12-04 04:08
截至月份: 2025年11月30日 狀態: 新提交 致:香港交易及結算所有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 公司名稱: 上海百心安生物技術股份有限公司 (於中華人民共和國註冊成立的股份有限公司) 呈交日期: 2025年12月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02185 | 說明 | H股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 235,703,422 | RMB | | 1 | RMB | | 235,703,422 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | 0 | | 本月底結存 | | | 235,703,422 | RMB | | 1 | RMB | ...
Wang Philip Li增持百心安-B1万股 每股均价6.66港元
Zhi Tong Cai Jing· 2025-12-03 08:12
香港联交所最新数据显示,12月1日,Wang Philip Li增持百心安-B(02185)1万股,每股均价6.66港元, 总金额6.66万港元。增持后最新持股数目为8501.77万股,持股比例为36.07%。 ...